MYCN and neuroblastoma: From a murine study with a transgenic mouse expressing MYCN targeted to the neural crest (TH-MYCN mice), the mouse develops neuroblastoma that begins with hyperplastic lesions in paravertebral ganglia within the first weeks after birth, escaping from the normal physiological process of cell death (46).